The summary of high tech capital raising in Q2 is out, and the IVC Research Center confirm what we've already knew - capital raising in Israel is showing seeds of recovery (see VC Cafe's post "Crisis Shmisis") with $343 million raised in 104 deals, representing an increase of 47% from the previous quarter. Life sciences continue to lead capital raising, attracting $109 million, and Israeli VC investments are a much smaller slice of the pie.